Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Refined Energy Corp. and Searchlight Resources Inc. Sign an Amendment to the Option Agreement for the Milner and Basin Properties
-
BioAtla Announces Regulatory Update on Clinical Development Plan for Ozuriftamab Vedotin in Oropharyngeal Squamous Cell Carcinoma (OPSCC) Following Productive Type B (End of Phase 2) Meeting with FDA
-
NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults
-
Enphase Energy Opens U.S. Pre-Orders for IQ9 Commercial Microinverters with GaN, Built for 480 V Three-Phase Systems
-
Aqua Metals Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
OncoC4 to Present Global Pivotal Phase 3 Trial Design for Next-Generation CTLA-4 Antibody Gotistobart Monotherapy Being Co-Developed with BioNTech in NSCLC at the IASLC 2025 World Conference on Lung C
-
Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting
-
Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy
-
Vaxart Announces Adjournment of Special Meeting of Stockholders
-
Genius Group appoints Saifedean Ammous as Board Advisor
-
Rezolve Ai CEO Engages Wall Street with Packed September Investor Line-Up
-
BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration
-
Aeries Technology Caps Eight Months of Momentum with Financial Turnaround, AI-Driven GCC Innovation, and Strategic Expansion
-
Juve Stabia’s Romeo Menti Stadium to Host “Final Four” of Italy’s First-Ever Serie A Women’s Cup from September 23-27
-
LM Funding America Announces August 2025 Production and Operational Update
-
Nuclear Power Industry Veteran Ralph Hunter Joins Board of Directors of ASP Isotopes Inc. and Board of Managers of Quantum Leap Energy LLC
-
Immutep Announces Data from EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma Accepted for Oral Presentation at CTOS 2025
-
GrowGeneration to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025
-
Stingray Elevates In-Car Entertainment with Next-Generation Karaoke Experience in BYD Vehicles
-
GlobalTech Announces Closing of $1.4M Private Placement Offering of Convertible Notes
-
Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment
-
Real-World Evidence Supports Clinical Effectiveness of neffy® (epinephrine nasal spray) in Patients Experiencing Anaphylaxis
-
Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy
-
Dakila Pesquisas announces the discovery of the “eighth musical note,” called kall
-
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
B-Stock’s Director of Strategic Operations, Joanie Stolos, Named Recipient of 2025 Women in Supply Chain Award
-
Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer
-
FOREWARN to Provide Identity Verification Services to Pacific Regional Multiple Listing Service to Promote Agent Safety
-
Suominen Corporation – Manager’s transaction: Charles Héaulmé
-
CoinShares to Go Public in the U.S. Through US$1.2 Billion Business Combination
-
Mohist AI Limited Launches TranGPT, an AI Translation and TTS SaaS Platform Empowering Cross-Border Professionals
-
Aviatrix® Cloud Native Security Fabric Wins 2025 Cloud Computing Security Excellence Award
-
ModelOp Announces 2025 AI Governance Leadership Summit on October 15 - The Agentic Advantage: How Enterprises Innovate Without Losing Control
-
SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds
-
Alterity Therapeutics Raises A$20.0 million in Strategic Placement
-
Plantro Withdraws Special Meeting Requisition After ISC Agrees to Strategic Review and Potential Sale
-
Composition of the shareholders’ nomination board of Harvia Plc
-
ElevateBio Appoints Larry Lockwood, Ph.D., as Chief Commercial Officer
-
Sparton Resources Inc. Pense Critical Metals Project Exploration Permits Received
-
PharmaCorp to Acquire a Pharmacy in Ontario for $5,300,000, New Non-Binding Letter of Intent to Acquire Two Pharmacies in Eastern Canada, Updates on Previously Announced Non-Binding Letters of Intent
-
Xtract One Selected by Delmar School District for Enhanced Security Solutions
-
TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment
-
Humanoid Global Announces Strategic Investment in RideScan, a Pioneer Advancing AI for Robotics Safety and Performance
-
Revival Gold Progresses Drilling and Development Activities at Mercur
-
FTI Consulting Appoints Shaun Rangappa, MD, MSHA, as Chief Clinical Executive and Senior Managing Director in Healthcare Business Transformation Practice
-
Share buy-back program
-
Angitia Biopharmaceuticals Presents First-in-Human Data on AGA2115 for Osteogenesis Imperfecta at ASBMR 2025
-
Important Notice to Long-Term Shareholders of Flywire Corporation (NASDAQ: FLYW); Ibotta, Inc. (NYSE: IBTA); SelectQuote, Inc. (NYSE: SLQT); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar La
-
Form 8.3 - [JTC PLC - 05 09 2025] - (CGAML)
-
Exodus Movement, Inc. August 2025 Treasury Update and Monthly Metrics
